Clinical Trials on Advanced Malignant Solid Tumors in Colombia
Total 374 results
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedTesticular Yolk Sac Tumor | Recurrent Ovarian Germ Cell Tumor | Recurrent Childhood Malignant Germ Cell Tumor | Recurrent Malignant Testicular Germ Cell Tumor | Childhood Extracranial Germ Cell Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular Germ Cell Tumor | Ovarian... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Pfizer; Hoffmann-La Roche; AstraZeneca; Seagen Inc.RecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid TumorsCanada
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Metastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Refractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Canada
-
Novartis PharmaceuticalsCompletedNeuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung OriginUnited States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Osteosarcoma | Refractory OsteosarcomaUnited States
-
ORIC PharmaceuticalsRecruitingSolid TumorsKorea, Republic of, United States, Australia, Taiwan, Poland, Canada, Hong Kong, United Kingdom
-
National Cancer Institute (NCI)RecruitingHIV Infection | Advanced Malignant Solid Neoplasm | Kaposi Sarcoma | Lung Carcinoma | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | Anal Carcinoma | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States, Australia
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Recurrent Melanoma | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Puerto Rico
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Neoplasm of Uncertain Malignant PotentialUnited States
-
Phio Pharmaceuticals Inc.Prosoft ClinicalRecruitingSquamous Cell Carcinoma of the Skin | Malignant Melanoma of Skin | Merkel Cell Carcinoma of SkinUnited States
-
DualityBio Inc.RecruitingHER2-positive Advanced Solid TumorChina, United States, Australia, Puerto Rico
-
St. Jude Children's Research HospitalMillennium Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.Active, not recruitingMalignant Rhabdoid Tumor | Atypical Teratoid Rhabdoid TumorUnited States
-
University of FloridaNational Cancer Institute (NCI); National Institutes of Health (NIH); National... and other collaboratorsActive, not recruitingHigh Grade Glioma | Malignant GliomaUnited States
-
Children's Oncology GroupCompletedRefractory or Recurrent Solid Tumors, Excluding CNS TumorsUnited States, Canada
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Hoffmann-La RocheCompleted
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Constantinos HadjipanayisMassachusetts General HospitalCompletedMalignant GliomasUnited States
-
INSYS Therapeutics IncPediatric Brain Tumor Consortium (PBTC), St. Jude Children's Research HospitalWithdrawnRecurrent Malignant GliomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Lung Carcinoid Tumor | Stage IV Renal Cell Cancer | Recurrent Digestive System Neuroendocrine Tumor G1 | Adult Solid Neoplasm | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma and other conditionsCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Neuroblastoma | Melanoma (Skin)United States, Canada, Australia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Sarcoma Alliance for Research through CollaborationBristol-Myers SquibbCompletedChondrosarcoma | Chordoma | Hemangiopericytoma | Rhabdomyosarcoma | Sarcoma, Alveolar Soft Part | Epithelioid Sarcoma | Gastrointestinal Stromal Tumor (GIST) | Giant Cell Tumor of Bone | Sarcoma, Ewing's | Malignant Peripheral Nerve Sheath TumorsUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)TerminatedBrain and Central Nervous System TumorsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada, Australia
-
National Cancer Institute (NCI)SuspendedLocally Advanced Leiomyosarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Locally Advanced Liposarcoma | Locally Advanced Undifferentiated Pleomorphic Sarcoma | Locally Advanced Extraskeletal Myxoid Chondrosarcoma | Locally Advanced Unresectable Soft Tissue SarcomaUnited States, Canada
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, China, Poland, Australia, Germany, Japan, Canada, Italy, Czechia, Spain, Turkey, United Kingdom, Sweden, Netherlands, France, Switzerland, Korea, Republic of, Denmark, Ireland, Israel, Ukraine
-
MedImmune LLCTerminatedAdvanced Solid Tumors | Aggressive B-cell LymphomasUnited States
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedExtragonadal Germ Cell Tumor | Childhood Germ Cell TumorCanada, United States, Australia, Puerto Rico
-
University of South FloridaNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chemotherapy-induced Nausea and Vomiting | Central Nervous System Tumor, PediatricUnited States, Canada
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Deep Vein Thrombosis | Pulmonary Embolism | Metastatic Malignant Solid Neoplasm | Cerebral Vein Thrombosis | Splanchnic Vein ThrombosisUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Teratoma | Stage II Malignant Testicular Germ Cell Tumor | Stage III Malignant Testicular Germ Cell Tumor | Childhood Embryonal Tumor | Childhood Extracranial Germ Cell Tumor | Childhood Extragonadal Germ Cell Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular... and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Georgetown UniversityHackensack Meridian Health; Karyopharm Therapeutics IncTerminatedThymoma | Advanced Thymic Epithelial TumorUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Sarcoma Alliance for Research through CollaborationUnited States Department of Defense; Synta Pharmaceuticals Corp.CompletedSarcoma | Malignant Peripheral Nerve Sheath Tumors (MPNST)United States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Glioma | WHO Grade 3 Glioma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Brain Neoplasm | Recurrent Childhood...United States
-
Children's Hospital Los AngelesUnknownBrain and Central Nervous System TumorsUnited States, Canada, Australia, Switzerland, New Zealand
-
Bristol-Myers SquibbNo longer availableStage III (Unresectable) or Stage IV Advanced MelanomaUnited States, Canada, Argentina, Colombia, Peru, Brazil
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)TerminatedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Brain and Central Nervous System Tumors | Carcinoma of Unknown PrimaryUnited States
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Thyroid Gland Carcinoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Thyroid Gland Medullary CarcinomaUnited States, Canada
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom